BackTalis Biomedical Overview

Talis Biomedical Other Liabilities

Track Talis Biomedical's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Talis Biomedical Other Liabilities History

Loading

Talis Biomedical vs. peers: Other Liabilities Comparison

Loading

Talis Biomedical Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Talis Biomedical (TLIS) FAQ

Talis Biomedical (TLIS) currently reports a other liabilities of $0 as of June 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Talis Biomedical's other liabilities history and peer comparisons.

Talis Biomedical's other liabilities changed from $0 to $0 (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Talis Biomedical reported $0 in other liabilities as of June 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Talis Biomedical, and consider following TLIS for alerts when major investors trade the stock.

Talis Biomedical is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLIS with unrelated industries.